EUVIMEDEUVIMED entdecken
Open Access

Outcomes Associated with Choice of Prophylactic Antibiotics in Open Fractures

Carol A Lin, Tim Kobes iD, Eric Kholodovsky iD, Giselle Hernandez iD, Nathan N O'Hara, Gregory M Schrank, Robert V O'Toole, Gerard P Slobogean iD, Sheila Sprague iD, Marilyn Heng iD, the PREP-IT Investigators

Journal of Bone and Joint Surgery · 2025

DOI: 10.2106/jbjs.24.01123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, 2025. Verfasst von Carol A Lin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cedars Sinai Medical Center, Los Angeles, California. Hauptthemen laut MEDLINE: Antibiotic Prophylaxis, Fractures, Open, Surgical Wound Infection, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The ideal antibiotic prophylaxis for open fractures is unknown. We evaluated outcomes following different antibiotic prophylaxis regimens for open fractures.

Methods

This is a secondary analysis of data from PREP-IT. Prophylactic antibiotics were defined as any intravenous antibiotic given on the day of admission. The outcomes were surgical site infection (SSI) within 90 days and reoperation within 1 year. Logistic regression and an instrumental variable analysis that leveraged site-level variation accounted for confounding. Subgroup variation was evaluated by stratifying by Gustilo-Anderson classification (Types I and II versus III).

Results

Of the 3,331 included participants, the mean age was 45 ± 18 years, 63% were male, 73% were White, 21% were Black, 2% were Asian, and 10% were Hispanic. Cefazolin monotherapy (58% of patients), ceftriaxone monotherapy (10%), and cefazolin plus gentamicin (6%) were the most common regimens. In the instrumental variable analysis, the odds of infection did not significantly differ with ceftriaxone use (odds ratio [OR], 1.24; 95% confidence interval [CI], 0.70 to 2.20; p = 0.45) or cefazolin plus gentamicin use (OR, 0.25; 95% CI, 0.03 to 2.04; p = 0.20) compared with cefazolin monotherapy. There were no significant differences between the regimens with respect to infection when stratified by Gustilo-Anderson type. However, we did observe a nearly 3-fold increase in the odds of infection with ceftriaxone use compared with cefazolin monotherapy (OR, 2.73; 95% CI, 0.96 to 7.79; p = 0.06) in Type-I and II fractures, and a 75% decrease in the odds of infection with cefazolin plus gentamicin use (OR, 0.25; 95% CI, 0.03 to 2.02; p = 0.19) compared with cefazolin monotherapy in Type-III fractures.

Conclusions

Among patients with open fractures, antibiotic prophylaxis with ceftriaxone monotherapy did not provide significant benefits compared with cefazolin monotherapy in preventing infection in Type-I and II fractures. The findings suggest that cefazolin plus gentamicin might reduce the odds of infection in Type-III fractures compared with cefazolin monotherapy, but this difference was not statistically significant. Level of Evidence: Therapeutic Level II . See Instructions for Authors for a complete description of levels of evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibiotic ProphylaxisFractures, OpenSurgical Wound InfectionAnti-Bacterial AgentsHumansMaleMiddle AgedFemaleCefazolinGentamicinsAdultCeftriaxoneDrug Therapy, CombinationTreatment OutcomeAgedRetrospective Studies

Substanzen

Anti-Bacterial AgentsCefazolinGentamicinsCeftriaxone

Autor:innen und Institutionen

  • Cedars Sinai Medical Center, Los Angeles, California.
  • University Medical Centre Utrecht, Utrecht, The Netherlands.
  • University of Miami Leonard M. Miller School of Medicine, Miami, Florida.
  • Center for Orthopaedic Injury Research and Innovation, R Adams Cowley Shock Trauma Center, Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland.
  • Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.

ORCID-Profile: Tim Kobes, Eric Kholodovsky, Giselle Hernandez, Gerard P Slobogean, Sheila Sprague, Marilyn Heng

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Lin, C. A., Kobes, T., Kholodovsky, E., Hernandez, G., O'Hara, N. N., Schrank, G. M., O'Toole, R. V., Slobogean, G. P., Sprague, S., Heng, M., & the PREP-IT Investigators (2025). Outcomes Associated with Choice of Prophylactic Antibiotics in Open Fractures. Journal of Bone and Joint Surgery. https://doi.org/10.2106/jbjs.24.01123

Vancouver

Lin CA, Kobes T, Kholodovsky E, Hernandez G, O'Hara NN, Schrank GM, et al. Outcomes Associated with Choice of Prophylactic Antibiotics in Open Fractures. Journal of Bone and Joint Surgery. 2025. doi:10.2106/jbjs.24.01123

BibTeX
@article{Lin2025,
  author = {Lin, Carol A and Kobes, Tim and Kholodovsky, Eric and Hernandez, Giselle and O'Hara, Nathan N and Schrank, Gregory M and O'Toole, Robert V and Slobogean, Gerard P and Sprague, Sheila and Heng, Marilyn and the PREP-IT Investigators, the PREP-IT Investigators},
  title = {Outcomes Associated with Choice of Prophylactic Antibiotics in Open Fractures},
  journal = {Journal of Bone and Joint Surgery},
  year = {2025},
  doi = {10.2106/jbjs.24.01123}
}
Kostenlos starten →